Global Diabetic Retinopathy Market 2015-2019

1
Top 10 Diabetes Care Technologies, Devices and
Therapeutics Markets - Growth, Global Share,
Industry Overview, Analysis, Trends Opportunities
and Forecast 2012 - 2020
Global Diabetic Retinopathy Market 2015-2019
2
Description
Report Overview
Diabetic retinopathy is a disorder of the eye
that damages the blood vessels of the retina. The
retina is the light-sensitive inner surface of
the eye on which images are formed. Long-term
diabetes affects the retina as high blood glucose
levels can damage the tiny blood vessels in the
retina. Diabetic retinopathy is broadly
classified into non-proliferative diabetic
retinopathy and proliferative retinopathy.
Treatment for diabetic retinopathy depends on the
stage of the disease and is directed toward
slowing down or stopping the progression of the
disease. Laser surgery, injection of
corticosteroids or anti-VEGF drugs into the eye,
and vitrectomy are some of the available
treatments. One feature of diabetic retinopathy
is diabetic macular edema. This is a serious
medical condition involving leakage of fluid from
the minute, delicate, and previously injured
blood vessels located at the back of the eye,
which then collects in the macula. This results
in inflammation of tissue and blurry
vision. Analysts forecast the global diabetic
retinopathy market to grow at a CAGR of 6.89
over the period 2014-2019. Read more details at
http//www.bigmarketresearch.com/global-diabetic-r
etinopathy-2015-2019-market
_at_Bigmarketresearch
3
Key Benefits
Description
The report also presents the vendor landscape and
a corresponding detailed analysis of the four
major vendors in the market. In addition, it
discusses the major drivers that influence the
growth and the challenges faced by the vendors
and the market at large, as well as the key
trends that contribute to the growth the market.
Global Diabetic Retinopathy Market 2015-2019,
has been prepared based on an in-depth market
analysis with inputs from industry experts. The
report covers the Americas, EMEA, and APAC it
also covers the global diabetic retinopathy
market landscape and its growth prospects in the
coming years. The report also includes a
discussion of the key vendors operating in this
market. Key Regions Americas APAC EMEA
_at_Bigmarketresearch
4
Description
Key Vendors Bayer F. Hoffmann-La Roche
Novartis Regeneron Pharmaceuticals Other
Prominent Vendors Actavis Alimera
Sciences Ampio Pharmaceuticals Antisense
Therapeutics BCN Peptides Boehringer
Ingelheim Glycadia
_at_Bigmarketresearch
5
Description
Market Driver Growth in patient population
For a full, detailed list, view our
report Market Challenge Availability of
effective surgical treatments For a full,
detailed list, view our report Market Trend
Launch of novel agents For a full, detailed
list, view our report Enquire About Report _at_
http//www.bigmarketresearch.com/report-enquiry/22
6096
_at_Bigmarketresearch
6
Table Of Contents
Table Of Content
01. Executive Summary 02. List of
Abbreviations 03. Scope of the Report 04. Market
Research Methodology 05. Introduction 06. Disease
Overview 07. Market Landscape 08. Pipeline
Portfolio 09. Market Segmentation by Type of
Molecule 10. Market Segmentation by Route of
Administration 11. Geographical Segmentation 12.
Buying Criteria 13. Market Growth Drivers 14.
Drivers and their Impact 15. Market
Challenges 16. Impact of Drivers and
Challenges 17. Market Trends 18. Trends and their
Impact 19. Vendor Landscape 20. Key Vendor
Analysis 21. Other Reports in this Series
_at_Bigmarketresearch
7
Get Full Information At http//www.bigmarketrese
arch.com/global-diabetic-retinopathy-2015-2019-mar
ket